(WH) Wyndham Hotels & Resorts - Overview
Sector: Consumer Cyclical | Industry: Lodging | Exchange: NYSE (USA) | Market Cap: 6.174m USD | Total Return: 4.2% in 12m
Industry Rotation: -0.7
Avg Turnover: 98.3M USD
Peers RS (IBD): 48.2
EPS Trend: -20.2%
Qual. Beats: 0
Rev. Trend: -4.4%
Qual. Beats: 0
Warnings
Altman Z'' 0.95 < 1.0 - financial distress zone
Tailwinds
No distinct edge detected
Wyndham Hotels & Resorts, Inc. (WH) is a hotel franchisor operating globally. The company licenses its numerous hotel brands to third-party owners, a common asset-light business model in the hospitality sector.
WHs portfolio includes a wide range of brands such as Super 8, Days Inn, and Wyndham Grand. They also offer related services and manage a guest loyalty program, which is crucial for customer retention in the competitive hotel industry.
Incorporated in 2017 and headquartered in Parsippany, New Jersey, WH operates within the Hotels, Resorts & Cruise Lines sub-industry.
Further research on platforms like ValueRay can provide deeper insights into WHs financial performance and market position.
- Franchise fee growth drives revenue expansion
- Loyalty program expansion boosts recurring income
- Global travel trends impact hotel occupancy rates
- Brand portfolio diversification mitigates market risks
| Net Income: 193.0m TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.08 > 0.02 and ΔFCF/TA 1.97 > 1.0 |
| NWC/Revenue: -9.94% < 20% (prev 0.07%; Δ -10.01% < -1%) |
| CFO/TA 0.09 > 3% & CFO 367.0m > Net Income 193.0m |
| Net Debt (2.99b) to EBITDA (482.0m): 6.21 < 3 |
| Current Ratio: 0.71 > 1.5 & < 3 |
| Outstanding Shares: last quarter (75.7m) vs 12m ago -3.93% < -2% |
| Gross Margin: 58.85% > 18% (prev 0.65%; Δ 5.82k% > 0.5%) |
| Asset Turnover: 34.00% > 50% (prev 33.29%; Δ 0.71% > 0%) |
| Interest Coverage Ratio: 3.02 > 6 (EBITDA TTM 482.0m / Interest Expense TTM 139.0m) |
| A: -0.03 (Total Current Assets 355.0m - Total Current Liabilities 497.0m) / Total Assets 4.18b |
| B: 0.11 (Retained Earnings 471.0m / Total Assets 4.18b) |
| C: 0.10 (EBIT TTM 420.0m / Avg Total Assets 4.20b) |
| D: 0.13 (Book Value of Equity 475.0m / Total Liabilities 3.71b) |
| Altman-Z'' Score: 0.95 = BB |
| DSRI: 1.06 (Receivables 291.0m/271.0m, Revenue 1.43b/1.41b) |
| GMI: 1.10 (GM 58.85% / 64.65%) |
| AQI: 1.03 (AQ_t 0.89 / AQ_t-1 0.87) |
| SGI: 1.02 (Revenue 1.43b / 1.41b) |
| TATA: -0.04 (NI 193.0m - CFO 367.0m) / TA 4.18b) |
| Beneish M-Score: -2.91 (Cap -4..+1) = A |
Over the past week, the price has changed by -0.02%, over one month by +7.10%, over three months by +5.05% and over the past year by +4.17%.
- StrongBuy: 9
- Buy: 5
- Hold: 1
- Sell: 0
- StrongSell: 0
| Analysts Target Price | 97 | 19.4% |
P/E Forward = 16.7504
P/S = 4.3207
P/B = 13.0651
P/EG = 0.6249
Revenue TTM = 1.43b USD
EBIT TTM = 420.0m USD
EBITDA TTM = 482.0m USD
Long Term Debt = 2.52b USD (from longTermDebt, last quarter)
Short Term Debt = 497.0m USD (from shortTermDebt, last quarter)
Debt = 3.06b USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 2.99b USD (from netDebt column, last quarter)
Enterprise Value = 9.17b USD (6.17b + Debt 3.06b - CCE 64.0m)
Interest Coverage Ratio = 3.02 (Ebit TTM 420.0m / Interest Expense TTM 139.0m)
EV/FCF = 28.56x (Enterprise Value 9.17b / FCF TTM 321.0m)
FCF Yield = 3.50% (FCF TTM 321.0m / Enterprise Value 9.17b)
FCF Margin = 22.46% (FCF TTM 321.0m / Revenue TTM 1.43b)
Net Margin = 13.51% (Net Income TTM 193.0m / Revenue TTM 1.43b)
Gross Margin = 58.85% ((Revenue TTM 1.43b - Cost of Revenue TTM 588.0m) / Revenue TTM)
Gross Margin QoQ = 22.46% (prev 92.41%)
Tobins Q-Ratio = 2.19 (Enterprise Value 9.17b / Total Assets 4.18b)
Interest Expense / Debt = 1.18% (Interest Expense 36.0m / Debt 3.06b)
Taxrate = 27.17% (72.0m / 265.0m)
NOPAT = 305.9m (EBIT 420.0m * (1 - 27.17%))
Current Ratio = 0.71 (Total Current Assets 355.0m / Total Current Liabilities 497.0m)
Debt / Equity = 6.53 (Debt 3.06b / totalStockholderEquity, last quarter 468.0m)
Debt / EBITDA = 6.21 (Net Debt 2.99b / EBITDA 482.0m)
Debt / FCF = 9.32 (Net Debt 2.99b / FCF TTM 321.0m)
Total Stockholder Equity = 550.0m (last 4 quarters mean from totalStockholderEquity)
RoA = 4.59% (Net Income 193.0m / Total Assets 4.18b)
RoE = 35.09% (Net Income TTM 193.0m / Total Stockholder Equity 550.0m)
RoCE = 13.70% (EBIT 420.0m / Capital Employed (Equity 550.0m + L.T.Debt 2.52b))
RoIC = 9.79% (NOPAT 305.9m / Invested Capital 3.12b)
WACC = 6.34% (E(6.17b)/V(9.23b) * Re(9.05%) + D(3.06b)/V(9.23b) * Rd(1.18%) * (1-Tc(0.27)))
Discount Rate = 9.05% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: -100.0 | Cagr: -4.82%
[DCF] Terminal Value 83.75% ; FCFF base≈289.0m ; Y1≈260.5m ; Y5≈224.4m
[DCF] Fair Price = 41.18 (EV 6.08b - Net Debt 2.99b = Equity 3.09b / Shares 75.1m; r=6.34% [WACC]; 5y FCF grow -12.25% → 3.0% )
EPS Correlation: -20.17 | EPS CAGR: -48.10% | SUE: -4.0 | # QB: 0
Revenue Correlation: -4.45 | Revenue CAGR: -2.76% | SUE: -0.27 | # QB: 0
EPS next Quarter (2026-06-30): EPS=1.37 | Chg7d=-0.002 | Chg30d=-0.002 | Revisions Net=-2 | Analysts=13
EPS current Year (2026-12-31): EPS=4.81 | Chg7d=-0.014 | Chg30d=-0.035 | Revisions Net=-1 | Growth EPS=+5.1% | Growth Revenue=+3.5%
EPS next Year (2027-12-31): EPS=5.38 | Chg7d=-0.013 | Chg30d=-0.030 | Revisions Net=-2 | Growth EPS=+11.8% | Growth Revenue=+5.7%
[Analyst] Revisions Ratio: -0.50 (1 Up / 3 Down within 30d for Next Quarter)
[Growth] Implied Growth Rate = 6.0% (Discount Rate 9.1% - Earnings Yield 3.0%)
[Growth] Growth Spread = -5.0% (Analyst 1.0% - Implied 6.0%)